EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder
NinaMED
May 14, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Otsuka has agreed to acquire Transcend in a deal described as $700M, focused on a PTSD drug platform. The transaction is announced as a platform acquisition in the substance-abuse-treatment and mental-health drug space.
Transcend is the target entity in the deal, and Otsuka is the strategic buyer.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
NinaMED
May 14, 2026
Prestige Consumer Healthcare→LaCorium Health
May 13, 2026
Golden Pet Brands→Petsource
May 13, 2026
PRISM Vision Group→Retina Macula Institute
May 13, 2026
Standard Dental Labs→BRLIT Dental Laboratory
May 13, 2026